Phreesia

In our efforts to continually enhance the CPP program, we are excited to announce a new partnership between CPP Buying Group and Phreesia, a leading provider of patient intake solutions. This collaboration aims to bring innovative, efficient, and streamlined patient intake and population health management processes, allowing you to focus on delivering exceptional care. 

Through this partnership, CPP Buying Group members will receive:

• Discounted pricing on a custom software package that includes:
• Patient Intake, Consent Management, Benefits Verification, Payment Processing
• Patient Chat
• Appointment Reminders and Confirmations
• Health Questionnaires & Screenings
• Health Campaigns for Patient Recall
• Digital Patient Engagement
• Phreesia On Call afterhours service

• Free 5-month trial to the first 10 new Phreesia customers (4 months free from Phreesia, 5^th month reimbursed by CPP up to $1,000 per practice). For more details contact us at cpp@nationwidechildrens.org.

·       

• Discounted optional add-on services like Patient Self Scheduling, Appointment Accelerator to Autofill Cancellations/No Shows, and Payment Assurance for Post-Visit Collections.

If you are already utilizing Phreesia in your office, contact us to discuss how you can benefit from this new partnership also!

We hope this partnership will deliver significant value by reducing administrative burdens and increasing operational efficiency to optimize patient care. Together with Phreesia, we are committed to supporting our providers with the best resources available to navigate the ever-evolving healthcare landscape.

For more information about Phreesia or to schedule a demo, click here. For more information about how this partnership can benefit your practice, please contact us at cpp@nationwidechildens.org.  

Novavax

In addition to discounts on the Moderna and Pfizer mRNA COVID vaccines, CPP members can now access a discount on the COVID vaccine manufactured by Novavax. Features of the Novavax vaccine for the 2024-2025 season can be found here.

Please contact the CPP office for current pricing sheets to see the discount details. Members who wish to participate in this opportunity must complete a Novavax declaration form and submit it to CPP. Doses can be purchased through any authorized Novavax vaccine distributor.

ACIP June Meeting

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) recently held a meeting on June 26-28. Meeting topics included:

RSV (Adults) – Adults 75 years and older are recommended to receive a single dose of RSV vaccine, using shared clinical decision-making with their healthcare provider.

• Adults aged 60 to 74 with chronic medical conditions or living in nursing homes are also recommended to receive a single RSV vaccine dose.

COVID-19 Vaccine – Individuals aged 6 months and older are recommended to receive the updated 2024-2025 COVID-19 vaccine, expected to be available in fall 2024.

Influenza Vaccine – Routine vaccination was recommended for everyone aged 6 months and older for the 2023–2024 season.

• High-dose and adjuvanted influenza vaccines were recommended for solid organ transplant recipients aged 18-64.

Pneumococcal Vaccine (PCV21) – Merck’s Capvaxive™ (PCV21) is recommended as an option for adults aged 19 years and older already recommended to receive a pneumococcal conjugate vaccine.

To review a summary of other topics discussed during June’s meeting click here.

Next Steps

If the CDC accepts these recommendations, they will be published in the MMWR within 90 days. This typically signals the insurance companies to begin paying for the newly recommended vaccines. We recommend reaching out to your major payers to make sure adequate payment is in place before incorporating a new vaccine into your schedule.

Merck Pricing

Beginning July 1, 2024, CPP members can now access enhanced savings on Merck’s Gardasil®9 and Vaxneuvance™ vaccine purchases.

Updated pricing sheets can be obtained by contacting the CPP office at cpp@nationwidechildrens.org.

As announced previously, all formulations of the 2024-2025 influenza vaccines will be trivalent this season. Therefore, billing codes for each of the vaccines have reverted to the trivalent set of CPT codes that was in place prior to quadrivalent formulations being available. Please see the updated guides from Sanofi and Seqirus and update your billing and coding processes accordingly!

Sanofi billing & coding guides

Seqirus billing & coding guides:

• Flucelvax®
• Flaud®
• Afluria®

2024 Payer Survey

Can you help us advocate for CPP member practices to receive prompt and proper payment for vaccines? Participating in this survey will also provide you with actionable insights into the financial health of your immunization services.

After completing the survey, participants will be able to answer key questions like:

• Are you appropriately raising your fees when vaccine price increases go into effect?
• Are your vaccine payments adequately covering your vaccine costs?
• Is your practice taking advantage of advance pricing notices to order vaccines before prices increase?
• How and when do you incorporate a new vaccine into your vaccine schedule?

Participants who complete the survey process will receive a $100 honorarium (provided as an Amazon gift card to the first 50 respondents, limit one per tax ID) as well as aggregated, de-identified data from all survey respondents. To get started click here.